Kimura R, Kimura H, Shirai T, Hayashi Y, Sato-Fujimoto Y, Kamitani W
Microorganisms. 2024; 12(9).
PMID: 39338486
PMC: 11434168.
DOI: 10.3390/microorganisms12091812.
Hasani S, Ghafouri E, Kouhpayeh S, Amerizadeh F, Rahimmanesh I, Amirkhani Z
Heliyon. 2023; 9(9):e19925.
PMID: 37809683
PMC: 10559356.
DOI: 10.1016/j.heliyon.2023.e19925.
Gonzalez-Mora A, Hernandez-Perez J, Iqbal H, Rito-Palomares M, Benavides J
Vaccines (Basel). 2020; 8(3).
PMID: 32899720
PMC: 7565293.
DOI: 10.3390/vaccines8030504.
Rasetti-Escargueil C, Popoff M
Toxins (Basel). 2019; 11(9).
PMID: 31547338
PMC: 6783819.
DOI: 10.3390/toxins11090528.
Rojas G, Tundidor Y, Cabrera Infante Y
MAbs. 2014; 6(6):1368-76.
PMID: 25484050
PMC: 4622681.
DOI: 10.4161/mabs.36144.
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.
Strotmeier J, Mahrhold S, Krez N, Janzen C, Lou J, Marks J
FEBS Lett. 2014; 588(7):1087-93.
PMID: 24583011
PMC: 4067265.
DOI: 10.1016/j.febslet.2014.02.034.
Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1.
Mukherjee J, McCann C, Ofori K, Hill J, Baldwin K, Shoemaker C
Toxins (Basel). 2013; 4(12):1565-81.
PMID: 23342681
PMC: 3528263.
DOI: 10.3390/toxins4121565.
Epitope mapping of botulinum neurotoxins light chains.
Zdanovsky A, Zdanovsky D, Zdanovskaia M
Toxicon. 2012; 60(7):1277-86.
PMID: 22922018
PMC: 3477267.
DOI: 10.1016/j.toxicon.2012.08.002.
Immunity to ricin: fundamental insights into toxin-antibody interactions.
OHara J, Yermakova A, Mantis N
Curr Top Microbiol Immunol. 2011; 357:209-41.
PMID: 22113742
PMC: 4433546.
DOI: 10.1007/82_2011_193.
Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.
Gray S, Barr J, Kalb S, Marks J, Baird C, Cangelosi G
Biotechnol Bioeng. 2011; 108(10):2456-67.
PMID: 21538339
PMC: 3203252.
DOI: 10.1002/bit.23196.
Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies.
Warner M, Grate J, Tyler A, Ozanich R, Miller K, Lou J
Biosens Bioelectron. 2009; 25(1):179-84.
PMID: 19643593
PMC: 2728038.
DOI: 10.1016/j.bios.2009.06.031.
Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
Scotcher M, McGarvey J, Johnson E, Stanker L
PLoS One. 2009; 4(3):e4924.
PMID: 19290051
PMC: 2654115.
DOI: 10.1371/journal.pone.0004924.
Mimotopes and proteome analyses using human genomic and cDNA epitope phage display.
B M, J M, M P
Comp Funct Genomics. 2008; 3(3):254-63.
PMID: 18628851
PMC: 2447272.
DOI: 10.1002/cfg.174.
Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.
Zarebski L, Vaughan K, Sidney J, Peters B, Grey H, Janda K
Expert Rev Vaccines. 2008; 7(1):55-74.
PMID: 18251694
PMC: 3319117.
DOI: 10.1586/14760584.7.1.55.
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.
Hill K, Smith T, Helma C, Ticknor L, Foley B, Svensson R
J Bacteriol. 2006; 189(3):818-32.
PMID: 17114256
PMC: 1797315.
DOI: 10.1128/JB.01180-06.
Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R, Forsyth C, LaPorte S, Geren I, Smith L, Marks J
J Mol Biol. 2006; 365(1):196-210.
PMID: 17059824
PMC: 1994578.
DOI: 10.1016/j.jmb.2006.09.084.
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
Smith T, Lou J, Geren I, Forsyth C, Tsai R, LaPorte S
Infect Immun. 2005; 73(9):5450-7.
PMID: 16113261
PMC: 1231122.
DOI: 10.1128/IAI.73.9.5450-5457.2005.
Epitope mapping using mRNA display and a unidirectional nested deletion library.
Ja W, Olsen B, Roberts R
Protein Eng Des Sel. 2005; 18(7):309-19.
PMID: 15980016
PMC: 2798801.
DOI: 10.1093/protein/gzi038.
The evolving field of biodefence: therapeutic developments and diagnostics.
Burnett J, Henchal E, Schmaljohn A, Bavari S
Nat Rev Drug Discov. 2005; 4(4):281-97.
PMID: 15803193
PMC: 7096857.
DOI: 10.1038/nrd1694.
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.
Nowakowski A, Wang C, Powers D, Amersdorfer P, Smith T, Montgomery V
Proc Natl Acad Sci U S A. 2002; 99(17):11346-50.
PMID: 12177434
PMC: 123259.
DOI: 10.1073/pnas.172229899.